rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Leroy E. Hood

Director

Company insider

Files Form 4 as: Director, Omeros.

Every Form 4 they filed

In numbers

Trades disclosed
32
Buys
0
Sells
0
Bought
$0
Sold
$0
Companies
1
Companies where not an officer
1
First trade
13 Oct 2009
Last trade
18 Jun 2026
Last filed
22 Jun 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
OMER OmerosDirector · Biotechnology · last 18 Jun 20260 buys · 0 sells

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
18 Jun 2026filed 22 Jun 2026OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
18 Jun 2026filed 22 Jun 2026OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
27 Jun 2025filed 1 Jul 2025OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
6 Jun 2024filed 7 Jun 2024OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
23 Jun 2023filed 27 Jun 2023OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
21 Sep 2022filed 23 Sep 2022OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
17 Jun 2022filed 22 Jun 2022OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
11 Jun 2021filed 14 Feb 2022OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
12 Feb 2021filed 17 Feb 2021OMER OmerosBiotechnologySEC FORM 4 Code M$23K5,000 at $4.53filing
12 Feb 2021filed 17 Feb 2021OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
5 Jun 2020filed 9 Jun 2020OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
13 Mar 2020filed 17 Mar 2020OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code M—5,000 at $0.00filing
13 Mar 2020filed 17 Mar 2020OMER OmerosBiotechnologySEC FORM 4 Code M$30K5,000 at $5.92filing
14 Dec 2019filed 17 Dec 2019OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code M—10,000 at $0.00filing
14 Dec 2019filed 17 Dec 2019OMER OmerosBiotechnologySEC FORM 4 Code M$76K10,000 at $7.56filing
7 Jun 2019filed 11 Jun 2019OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
15 Jun 2018filed 18 Jun 2018OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
16 Jun 2017filed 16 Jun 2017OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—10,000 at $0.00filing
9 Jun 2016filed 10 Jun 2016OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—7,500 at $0.00filing
22 May 2015filed 27 May 2015OMER Omerosoption or derivative · BiotechnologySEC FORM 4 Code A—5,000 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

No trade we could place in a sector.

Related people

David J. BorgesVP, Finance & CAO · VP, Finance & CAO at Omeros, filing Form 4 there in the last year
Peter B. CancelmoVP, General Counsel · VP, General Counsel at Omeros, filing Form 4 there in the last year
Arnold C. HanishDirector · Director at Omeros, filing Form 4 there in the last year
Thomas J. CableDirector · Director at Omeros, filing Form 4 there in the last year
Joseph L. SchockenDirector · Director at Omeros, filing Form 4 there in the last year